stockrowVir Biotechnology, Inc.
VIRVir Biotechnology, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $68.6 million, down 7.61% from fiscal 2024.
- Revenue
- −178.3%
- EPS
- +51.4%
- Free cash flow
- +36.8%
Quarter to September 2026, against a year earlier
Follow VIR
Alert me
Vir Biotechnology, Inc. (VIR) Revenue growth
Vir Biotechnology, Inc.'s revenue growth over the twelve months to 30 September 2026 was 1,696.0%, up 1703.6 percentage points from fiscal 2025 (−7.61%). Over the past ten years it has ranged from −94.7% (fiscal 2023) to 1,334.4% (fiscal 2021); the current reading is higher than 56% of that period. That is above the Biotechnology industry median of 6.78% and above the Healthcare sector median of 8.11%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | −7.61% | 6.29 |
| FY2024 | −13.9% | 80.77 |
| FY2023 | −94.7% | (142.18) |
| FY2022 | 47.5% | (1,286.88) |
| FY2021 | 1,334.4% | 490.53 |
| FY2020 | 843.9% | 868.02 |
| FY2019 | −24.2% | (318.10) |
| FY2018 | 293.9% | 366.67 |
| FY2017 | −72.7% | — |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Sep 2026 | −178.3% | (19,760.87) |
| Jun 2026 | 19,582.5% | 19,683.50 |
| Mar 2026 | −101.0% | (518.74) |
| Dec 2025 | 417.8% | 507.70 |
| 28 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| VIR Vir Biotechnology, Inc. | 1,696.0% |
| BHVN Biohaven Ltd. compare | 425.2% |
| ZYME Zymeworks Inc. compare | 97.8% |
| RXRX Recursion Pharmaceuticals, Inc. compare | 56.2% |
| IMNM Immunome, Inc. compare | 16.7% |
| NAMS NewAmsterdam Pharma Company N.V. compare | −26.4% |
| LKFT Lakefront Biotherapeutics - Sponsored ADR compare | −52.2% |
| TRAX First Tracks Biotherapeutics, Inc. compare | — |
| REPL Replimune Group, Inc. compare | — |
| Biotechnology industry median | 6.78% |
| Healthcare sector median | 8.11% |
| Market median | 7.71% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on VIR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- The full statement